ASCO 2015 - Long-term consequences of intermittent and continuous androgen deprivation in men with metastatic prostate cancer - Session Highlights

CHICAGO, IL USA (UroToday.com) - Dr. Dawn Hershman of Columbia University discussed outcomes from the SWOG S9346 study evaluating men with metastatic prostate cancer receiving intermittent vs continuous androgen deprivation therapy (ADT).

ASCO - Now or later: Optimal timing of docetaxel for metastatic prostate cancer: Early treatment with docetaxel chemotherapy - Session Highlights

CHICAGO, IL USA (UroToday.com) - Maha Hussain, Professor of Medicine and Urology at the University of Michigan, and Howard Scher, Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center artfully presented point and counterpoint debating the timing of docetaxel chemotherapy in advanced prostate cancer given the changing therapeutic landscape.

ASCO - Now or later: Optimal timing of docetaxel for metastatic prostate cancer: Late treatment with docetaxel chemotherapy - Session Highlights

CHICAGO, IL USA (UroToday.com) - Maha Hussain, Professor of Medicine and Urology at the University of Michigan, and Howard Scher, Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center artfully presented point and counterpoint debating the timing of docetaxel chemotherapy in advanced prostate cancer given the changing therapeutic landscape.

ASCO - Bottom line: Timing of treatment with docetaxel for men with advanced prostate cancer - Session Highlights

CHICAGO, IL USA (UroToday.com) - Drs. Maha Hussain and Howard Scher, two leaders in the field of prostate cancer, presented opposing views regarding whether docetaxel chemotherapy should be incorporated early versus late during the treatment of men with advanced prostate cancer.

Page 2 of 2
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe